Quality Control Indexes for Oncology (2023 edition) and hot topics in breast surgery
10.3760/cma.j.cn112139-20230829-00071
- VernacularTitle:《肿瘤专业医疗质量控制指标（2023年版）》与乳腺外科热点问题
- Author:
Ling XIN
1
;
Hongyu XIANG
;
Jingming YE
;
Yinhua LIU
Author Information
1. 北京大学第一医院甲状腺乳腺外科，北京 100034
- Keywords:
Breast neoplasms;
Surgical procedures, operative;
Quality control;
Standardized diagnosis and treatment
- From:
Chinese Journal of Surgery
2024;62(2):93-98
- CountryChina
- Language:Chinese
-
Abstract:
The National Health Commission of the People′s Republic of China has formulated the Quality Control Indexes for Oncology (2023 edition), with the objective of improving medical quality scientifically, refined and standardized. Among these indexes, the rate of pretreatment clinical TNM staging and the coincidence rate of evaluation of pretreatment TNM staging lay national standards for patients to formulate rational and targeted treatment strategies. This article reviewed the literature and referred to Chinese Medical Association Clinical Practice Guide for Breast Surgery, and presented recommendations for the hot topics of breast surgery, such as pathological sampling of the breast specimen, sentinel lymph node biopsy for early-stage breast cancer, breast conserving surgery, axillary lymph node dissection, breast reconstruction surgery, endoscopic-assisted breast surgery, the principles of surgical treatment for metastatic breast cancer, neoadjuvant treatment for advanced disease, and surgical grade of breast surgery, which have been widely concerned in recent years, to help improve homogenization of breast cancer treatment in China.
